Please assess the completion status of the following clinical trial:

Trial Title: Tamoxifen in Treatment of Acute Mania

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. diagnosis of BD I, most recent episode, manic or mixed,~2. ages 18-65,~3. Young Mania Rating Scale (YMRS) score \> 20 at screening and baseline,~4. providing written informed consent.~Exclusion Criteria:~1. currently pregnant, planning to become pregnant, or breast feeding,~2. history of any coagulopathies, deep vein thrombosis, pulmonary embolus,~3. a history of hypersensitivity to tamoxifen,~4. drug screen positive for any drug of abuse at screening, active substance abuse in the past 2 weeks or substance dependence in the past 2 months (except nicotine and caffeine),~5. diagnosis of schizophrenia, dementia, delirium, seizure disorder, obsessive compulsive disorder, or major cardiac, hepatic or renal disease that is unstable or that requires medical care,~6. administration of any other investigational drug in the last 30 days,~7. clinically significant suicidal or homicidal ideation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Tamoxifen Citrate (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).